Home / Cyclophosphamide / Belgium
BE ATC L01AA01 · updated 2 Nov 2026
Cyclophosphamide shortage in Belgium
Is there a Cyclophosphamide shortage in Belgium?
Yes. As of 2 Nov 2026, 2 Cyclophosphamide products are reported short in Belgium, the first since 22 Jun 2026. The company estimate for the return is 31 Dec 2026. Main reason: manufacturing problem.
Also short in Canada, Germany, France, Italy, Spain, Austria, Switzerland, Czechia, Sweden, Japan, Australia. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Endoxan 1 g inj./inf. sol. (pwdr.) i.m./i.v. vial 1000 mg limited | Baxter | 22 Jun 2026 | 31 Dec 2026 | Manufacturing problem Delay in production |
| BE | Endoxan 500 mg inj./inf. sol. (pwdr.) i.m./i.v. vial 5 x 500 mg limited | Baxter | 22 Jun 2026 | 31 Dec 2026 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.